TechCentralTechCentral
    Facebook Twitter YouTube LinkedIn
    Facebook Twitter LinkedIn YouTube
    TechCentral TechCentral
    NEWSLETTER
    • News

      Signs Eskom crisis is creating diesel shortages

      30 June 2022

      Management shake-up at Absa

      30 June 2022

      Eskom ramps up load shedding as crisis deepens

      30 June 2022

      Alviva shares leap higher on R3-billion take-private offer

      30 June 2022

      Huawei, MTN to help build 5G-powered ‘smart mine’

      30 June 2022
    • World

      Graphics card prices plummet as crypto demand dries up

      30 June 2022

      Bitcoin just had its worst quarter in a decade

      30 June 2022

      The NFT party is over

      30 June 2022

      Samsung beats TSMC to 3nm chip production

      30 June 2022

      Napster plots crypto comeback

      29 June 2022
    • In-depth

      The great crypto crash: the fallout, and what happens next

      22 June 2022

      Goodbye, Internet Explorer – you really won’t be missed

      19 June 2022

      Oracle’s database dominance threatened by rise of cloud-first rivals

      13 June 2022

      Everything Apple announced at WWDC – in less than 500 words

      7 June 2022

      Sheryl Sandberg’s ad empire leaves a complicated legacy

      2 June 2022
    • Podcasts

      How your organisation can triage its information security risk

      22 June 2022

      Everything PC S01E06 – ‘Apple Silicon’

      15 June 2022

      The youth might just save us

      15 June 2022

      Everything PC S01E05 – ‘Nvidia: The Green Goblin’

      8 June 2022

      Everything PC S01E04 – ‘The story of Intel – part 2’

      1 June 2022
    • Opinion

      Has South Africa’s advertising industry lost its way?

      21 June 2022

      Rob Lith: What Icasa’s spectrum auction means for SA companies

      13 June 2022

      A proposed solution to crypto’s stablecoin problem

      19 May 2022

      From spectrum to roads, why fixing SA’s problems is an uphill battle

      19 April 2022

      How AI is being deployed in the fight against cybercriminals

      8 April 2022
    • Company Hubs
      • 1-grid
      • Altron Document Solutions
      • Amplitude
      • Atvance Intellect
      • Axiz
      • BOATech
      • CallMiner
      • Digital Generation
      • E4
      • ESET
      • Euphoria Telecom
      • IBM
      • Kyocera Document Solutions
      • Microsoft
      • Nutanix
      • One Trust
      • Pinnacle
      • Skybox Security
      • SkyWire
      • Tarsus on Demand
      • Videri Digital
      • Zendesk
    • Sections
      • Banking
      • Broadcasting and Media
      • Cloud computing
      • Consumer electronics
      • Cryptocurrencies
      • Education and skills
      • Energy
      • Fintech
      • Information security
      • Internet and connectivity
      • Internet of Things
      • Investment
      • IT services
      • Motoring and transport
      • Public sector
      • Science
      • Social media
      • Talent and leadership
      • Telecoms
    • Advertise
    TechCentralTechCentral
    Home»Sections»IT services»nuvoteQ delivers a safe clinical trial for vaccine roll-out in India

    nuvoteQ delivers a safe clinical trial for vaccine roll-out in India

    IT services By EOH Holdings11 February 2022
    Facebook Twitter LinkedIn WhatsApp Telegram Email

    Towards the middle of 2020, when the Covid-19 pandemic closed borders and drove most countries into lockdown, nuvoteQ* was approached by a life science pharmaceutical company in India with a very specific need: it was looking for a life-science clinical trials platform. The strict timelines of this specific study required us to be quite imaginative in the way we approached the project.

    Our electronic direct capturing (EDC) platform helped expedite the vaccine’s time to market.

    The solution involved the deployment of our proprietary, Web-based software solution (Nukleus), an EDC platform designed for the collection of clinical data in electronic format for use mainly in human clinical trials. Using Nukleus, which we host with Amazon Web Services solutions, we were able to streamline data collection, which helped expedite the vaccine’s time to market.

    A solution delivered in two weeks

    We were able to repurpose a lot of previous studies, and all of the data created the foundation of this particular study. As a result, we were able to create specific categories in two weeks — a process that would typically take eight to 12 weeks. It’s been a great honour to help deliver a solution aimed at curbing the pandemic in the world’s most  populous country.

    Watch how we used software to solve for a safe clinical trial in India’s vaccine roll-out:

    For more, visit www.eoh.co.za/imagine.

    * nuvoteQ is a Proudly EOH company

    • This promoted content was paid for by the party concerned
    EOH Nukleus nuvoteQ
    Share. Facebook Twitter LinkedIn WhatsApp Telegram Email
    Previous ArticleDisney closes the gap with Netflix
    Next Article South Africa’s new critical skills list: What it means for the ICT industry

    Related Posts

    Graphics card prices plummet as crypto demand dries up

    30 June 2022

    Signs Eskom crisis is creating diesel shortages

    30 June 2022

    Management shake-up at Absa

    30 June 2022
    Add A Comment

    Comments are closed.

    Promoted

    Think herding cats is tricky? Try herding a cloud

    29 June 2022

    How your business can help hybrid workers effectively

    28 June 2022

    Hands off our satellite spectrum!

    27 June 2022
    Opinion

    Has South Africa’s advertising industry lost its way?

    21 June 2022

    Rob Lith: What Icasa’s spectrum auction means for SA companies

    13 June 2022

    A proposed solution to crypto’s stablecoin problem

    19 May 2022

    Subscribe to Updates

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    © 2009 - 2022 NewsCentral Media

    Type above and press Enter to search. Press Esc to cancel.